Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1958 1
1961 2
1964 2
1965 1
1966 1
1967 1
1968 2
1969 4
1970 8
1971 8
1972 12
1973 16
1974 22
1975 14
1976 17
1977 15
1978 31
1979 34
1980 38
1981 31
1982 22
1983 27
1984 32
1985 36
1986 28
1987 41
1988 35
1989 43
1990 42
1991 59
1992 65
1993 61
1994 82
1995 87
1996 92
1997 101
1998 109
1999 114
2000 134
2001 175
2002 178
2003 201
2004 273
2005 280
2006 340
2007 374
2008 417
2009 458
2010 521
2011 611
2012 594
2013 666
2014 689
2015 811
2016 813
2017 839
2018 884
2019 983
2020 1212
2021 1385
2022 1544
2023 1368
2024 1526
2025 1815
2026 472

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,663 results

Results by year

Filters applied: . Clear all
Page 1
Selected Abstracts.
Lin M, Dolejs S, Garcia-Henriquez N, Batra R. Lin M, et al. Dis Colon Rectum. 2026 Jan 1;69(1):95-99. doi: 10.1097/DCR.0000000000003991. Epub 2025 Oct 20. Dis Colon Rectum. 2026. PMID: 41432916 No abstract available.
Selected Abstracts.
Dolejs S, Akram W, Eisenstein S, Lin M. Dolejs S, et al. Among authors: lin m. Dis Colon Rectum. 2026 Feb 1;69(2):256-259. doi: 10.1097/DCR.0000000000004030. Epub 2025 Nov 6. Dis Colon Rectum. 2026. PMID: 41538383 No abstract available.
Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab.
Mishra A, Meador CB, Kikkeri K, Cunneely Q, Lin M, Carmona-LaSalle TJ, Huang SB, Bell R, Putaturo V, Xia W, Liang JH, Fang J, San Vicente S, Zielinski CE, Digumarthy SR, Hung YP, Yeap BY, Edd JF, Lawrence MS, Sade-Feldman M, Sen DR, Toner M, Maheswaran S, Gainor JF, Haber DA. Mishra A, et al. Among authors: lin m. Cancer Discov. 2026 Jan 14. doi: 10.1158/2159-8290.CD-25-1483. Online ahead of print. Cancer Discov. 2026. PMID: 41532856
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Mateus-Tique J, Lakshmi A, Singh B, Iyer R, Sánchez-Paulete AR, Falcomatà C, Lin M, Pantsulaia G, Tepper A, Nguyen T, Amabile A, Mollaoglu G, Pia L, Chhamalwan D, Le Berichel J, Potak H, Colonna M, Baccarini A, Brody J, Merad M, Brown BD. Mateus-Tique J, et al. Among authors: lin m. Cancer Cell. 2026 Jan 22:S1535-6108(25)00555-0. doi: 10.1016/j.ccell.2025.12.021. Online ahead of print. Cancer Cell. 2026. PMID: 41576929
Netarsudil-associated conjunctival fragility.
Vongsachang H, Davtyan E, Lin MM, Shen LQ, Margeta MA. Vongsachang H, et al. Among authors: lin mm. Am J Ophthalmol Case Rep. 2026 Jan 29;41:102533. doi: 10.1016/j.ajoc.2026.102533. eCollection 2026 Mar. Am J Ophthalmol Case Rep. 2026. PMID: 41675443 Free PMC article.
18,663 results
You have reached the last available page of results. Please see the User Guide for more information.